152 related articles for article (PubMed ID: 37996954)
1. Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates.
Wakileh GA; Bierholz P; Kotthoff M; Skowron MA; Bremmer F; Stephan A; Anbuhl SM; Heukers R; Smit MJ; Ströbel P; Nettersheim D
Exp Hematol Oncol; 2023 Nov; 12(1):96. PubMed ID: 37996954
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
3. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
Daniel SK; Seo YD; Pillarisetty VG
Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
[TBL] [Abstract][Full Text] [Related]
4. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
[TBL] [Abstract][Full Text] [Related]
5. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
6. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
9. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
[TBL] [Abstract][Full Text] [Related]
13. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
15. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
Xu D; Li R; Wu J; Jiang L; Zhong HA
Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
[TBL] [Abstract][Full Text] [Related]
17. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
18. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
[TBL] [Abstract][Full Text] [Related]
19. The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer.
Shi Y; Riese DJ; Shen J
Front Pharmacol; 2020; 11():574667. PubMed ID: 33363463
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
Gonçalves TL; de Araújo LP; Pereira Ferrer V
Cytokine; 2023 Oct; 170():156344. PubMed ID: 37639844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]